Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
QuintilesIMS
Farmers Insurance
Johnson and Johnson
McKesson
US Department of Justice
Chubb
Harvard Business School

Generated: November 18, 2018

DrugPatentWatch Database Preview

Fougera Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS, and what generic alternatives to FOUGERA PHARMS drugs are available?

FOUGERA PHARMS has one hundred and twelve approved drugs.

There are four US patents protecting FOUGERA PHARMS drugs.

Summary for Fougera Pharms
US Patents:4
Tradenames:53
Ingredients:45
NDAs:112

Drugs and US Patents for Fougera Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc FLUOCINONIDE fluocinonide CREAM;TOPICAL 200735-001 Jul 14, 2014 AB RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 088167-001 Dec 16, 1982 AT RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms HALOBETASOL PROPIONATE halobetasol propionate CREAM;TOPICAL 077001-001 Dec 16, 2004 AB RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms MOMETASONE FUROATE mometasone furoate OINTMENT;TOPICAL 077061-001 Mar 28, 2005 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Fougera Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,852,002 ➤ Sign Up
Fougera Pharms ACLOVATE alclometasone dipropionate CREAM;TOPICAL 018707-001 Dec 14, 1982 4,124,707 ➤ Sign Up
Fougera Pharms TEMOVATE clobetasol propionate CREAM;TOPICAL 019322-001 Dec 27, 1985 3,721,687 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,985,850 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for FOUGERA PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Gel 3% ➤ Subscribe 2009-12-16
➤ Subscribe Lotion 0.05% ➤ Subscribe 2008-07-28

Supplementary Protection Certificates for Fougera Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012 00040 Denmark ➤ Sign Up PRODUCT NAME: EN BLANDING AF CATECHINER ISOLERET FRA ET EKSTRAKT AF GROEN TE (CAMELLIA SINENSIS (L.) O. KUNTTZE) , HERUNDER (-)-EPIGALLOCATECHINGALLAT; NAT. REG. NO/DATE: 49803 (DK) 20120702; FIRST REG. NO/DATE: DE 73486.00.00 20090831
2013025,C1304992 Lithuania ➤ Sign Up PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
C0058 France ➤ Sign Up PRODUCT NAME: EXTRAIT SEC RAFFINE DE FEUILLE DE THE VERT (CAMELLIA SINENSIS (L.) O. KUNTZE) QUANTIFIE EN GALLATE D'(-)-EPIGALLOCATECHINE; NAT. REGISTRATION NO/DATE: NL41799 20120625; FIRST REGISTRATION: DE - 73186.00.00 20090831
0842660/01 Switzerland ➤ Sign Up PRODUCT NAME: CAMELLIAE SINENSIS EXTRACTUM SICCUM RAFFINATUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 61895 27.03.2012
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Johnson and Johnson
Julphar
Dow
Express Scripts
Daiichi Sankyo
Federal Trade Commission
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.